(Q45810853)

16 December 2017

title

Oral bisphosphonate use in the elderly is not associated with acute kidney injury (English)

1 reference

16 December 2017

13

Amit X Garg

1 reference

16 December 2017

Chirag R Parikh

10

object named as

Chirag R Parikh

1 reference

16 December 2017

Suzanne M. Cadarette

12

object named as

Suzanne M Cadarette

1 reference

16 December 2017

author name string

Andrew W Y Shih

1

1 reference

16 December 2017

Matthew A Weir

2

1 reference

16 December 2017

Kristin K Clemens

3

1 reference

16 December 2017

Zhan Yao

4

1 reference

16 December 2017

Tara Gomes

5

1 reference

16 December 2017

Muhammad M Mamdani

6

1 reference

16 December 2017

David N Juurlink

7

1 reference

16 December 2017

Amanda Hird

8

1 reference

16 December 2017

Anthony Hodsman

9

1 reference

16 December 2017

Ron Wald

11

1 reference

16 December 2017

language of work or name

English

0 references

publication date

13 June 2012

1 reference

16 December 2017

published in

Kidney International

1 reference

16 December 2017

volume

82

1 reference

16 December 2017

issue

8

1 reference

16 December 2017

page(s)

903-908

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2012.227

exact match

0 references

cites work

Bisphosphonates and osteonecrosis of the jaw: innocent association or significant risk?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Recent advances in understanding the mechanism of action of bisphosphonates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Altered gene expression and functions of mitochondria in human nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Protein prenylation: molecular mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Bisphosphonate nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Renal Failure with the Use of Zoledronic Acid

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Clinical pharmacology of alendronate sodium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Acute renal failure and alendronate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

The risk of acute renal failure in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Incidence and outcomes in acute kidney injury: a comprehensive population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Prescriptions for Estrogen Replacement Therapy in Ontario Before and After Publication of the Women's Health Initiative Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Drug-drug interactions among elderly patients hospitalized for drug toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Persistence with bisphosphonate therapy in older people

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

The RIFLE criteria and mortality in acute kidney injury: A systematic review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.227

7 January 2021

Identifiers

DOI

10.1038/KI.2012.227

1 reference

16 December 2017

Dimensions Publication ID

1025246575

0 references

1 reference

16 December 2017